Regulation Library
A continuously maintained archive of regulatory analysis, NMPA updates and practice Q&As — built to help you understand China's medical device oversight.
“China FDA website”? Finding the NMPA and the official portals
There is no current agency called China FDA. A guide to the NMPA, its official Chinese and English sites, and how regulatory responsibilities are divided.
China medical device regulations PDF: official sources and version control
The two foundational texts, the regulatory hierarchy, where to download official PDFs, and how to check that an English copy is still current.
Provisions for Medical Device Registration and Filing (Decree No. 47) explained
Registration versus filing, Class I–III routes for imported devices, the China legal agent, Chinese-language dossiers, home-market evidence and clinical evaluation.
How to register a medical device in China — a guide for foreign manufacturers
Classification, agent appointment, the seven-section dossier, testing and clinical evaluation, statutory review clocks, realistic timelines and cost structure.
China legal agent for medical devices: duties, requirements and how to change one
The in-country representative under Decree 739 and Order 47 — distinct from distributors and EU authorized representatives.
Clinical evaluation in China: exemptions, same-variety route and clinical trials
Three evidence routes under Decree 739 Articles 24–29 and Order 47 Articles 33–46 — and how to use foreign data.
How to enter the Chinese medical device market: a practical roadmap
No registration, no import: roles, import compliance, special pathways and ten steps from assessment to first shipment.
Decree No. 739 in brief: what overseas manufacturers need to know
Core obligations of overseas registrants, China legal agents and post-market duties under the revised Regulations.
Classification Catalogue dynamic adjustments explained
How the catalogue is updated, and what adjustments mean for products already on or entering the market.
UDI rollout tracker
Implementation batches, product scope and a step-by-step checklist for overseas manufacturers.
Post-market obligations & vigilance Q&A
Ongoing duties, vigilance reporting timelines and recall coordination — in practical terms.
Announcements & guidance tracker
Which official publications matter, how they affect exporters, and a four-step framework you can copy.
Submission practice Q&A
Classification, legal agents, dossiers, foreign clinical data, renewals and changes — answered from practice.
Want a clearer route into the Chinese market?
Beyond the library, we would be glad to discuss your product and your China market plan.
